Alnylam Pharmaceuticals (ALNY) Projected to Post Quarterly Earnings on Thursday
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) is anticipated to release its Q1 2025 earnings data before the market opens on Thursday, May 1st. Analysts expect the company to announce earnings of ($0.55) per share and revenue of $584.32 million for the quarter. Alnylam Pharmaceuticals has set its FY 2025 guidance at EPS. Alnylam Pharmaceuticals […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) is anticipated to release its Q1 2025 earnings data before the market opens on Thursday, May 1st. Analysts expect the company to announce earnings of ($0.55) per share and revenue of $584.32 million for the quarter. Alnylam Pharmaceuticals has set its FY 2025 guidance at EPS. Alnylam Pharmaceuticals […]
